Advertisement
Advertisement
U.S. markets open in 4 hours 9 minutes
Advertisement
Advertisement
Advertisement
Advertisement

Eli Lilly and Company (LLY)

NYSE - NYSE Delayed Price. Currency in USD
Add to watchlist
248.44+3.39 (+1.38%)
At close: 4:03PM EDT
249.60 +1.16 (+0.47%)
Pre-Market: 05:10AM EDT
Advertisement
Full screen
Trade prices are not sourced from all markets
Gain actionable insight from technical analysis on financial instruments, to help optimize your trading strategies
Chart Events
Bullishpattern detected
Price Crosses Moving Average

Price Crosses Moving Average

Previous Close245.05
Open244.50
Bid0.00 x 1000
Ask0.00 x 1000
Day's Range237.09 - 248.92
52 Week Range129.21 - 275.87
Volume4,530,578
Avg. Volume2,563,864
Market Cap237.653B
Beta (5Y Monthly)0.31
PE Ratio (TTM)37.36
EPS (TTM)6.65
Earnings DateOct 26, 2021
Forward Dividend & Yield3.40 (1.39%)
Ex-Dividend DateNov 12, 2021
1y Target EstN/A
Fair Value is the appropriate price for the shares of a company, based on its earnings and growth rate also interpreted as when P/E Ratio = Growth Rate. Estimated return represents the projected annual return you might expect after purchasing shares in the company and holding them over the default time horizon of 5 years, based on the EPS growth rate that we have projected.
Fair Value
XX.XX
Near Fair Value
4% Est. Return

Subscribe to Yahoo Finance Plus to view Fair Value for LLY

Learn more
View details
Research that delivers an independent perspective, consistent methodology and actionable insight
Related Research
  • Eli Lilly and Company
    Analyst Report: Eli Lilly and CompanyEli Lilly is a drug firm with a focus on neuroscience, endocrinology, oncology, and immunology. Lilly's key products include Alimta and Verzenio for cancer; Jardiance, Trulicity, Humalog, and Humulin for diabetes; and Taltz and Olumiant for immunology.
    Rating
    Fair Value
    Economic Moat
    17 hours agoMorningstar
View more
Advertisement
Advertisement